Why Ford's Plan to Move On From Sedans Is Risky
Ford's SUV-heavy plan is a solid one, but it comes with a risk.
What Kroger Wants Investors to Know
The retailer sees momentum building in the second year of its three-year recovery plan.
The Market Breaks Its IPO Fever
Based on its ill-fated road show, WeWork may be the tipping point for absurdly valued, flashy IPOs.
Most are hard to get and require a lot of training.
The stock is coming off a new low and could be a steal of a deal given how much growth it could achieve.
Cannabis stocks have been awful since the end of March, and that trend may continue for a while.
These stocks are an income investor's dream come true.
The second attempt at spinning off the international division could still allow the company to come out ahead in the end.
Amgen's recent clinical setback just might prompt the big biotech to light a fire beneath its acquisition efforts.
These 2 Cannabis Companies Kicked In Over $1 Million to Legalize Pot in Florida. Will Their Bets Pay Off?
Sunny beaches, popular theme parks -- and recreational marijuana? Big bucks are flowing in to make legal pot in Florida a reality.
Owning a home makes people happier, but that does not mean it's for everyone.
It happens to everyone, but how you handle it can be very important.
Every dollar makes a difference -- as you'll see.
The underlying philosophy of the retail giant's model is simple: Give the customer what they want, how they want it.
The quick answer: It depends.
One rose-tinted report doesn’t change the underlying business model problems for the ride-sharing darlings.
WeWork’s debacle of an IPO continues to stumble along, while Apple’s updates suggest a strong long-term future.
An FDA ban on vapes would change the tobacco market in a huge way.
WeWork’s disastrous IPO plans feel like the end of an era of over-hyped buzz IPOs.
More people, more stuff, more consumption -- and somebody’s got to haul away the trash.
There’s a serious transition going on in the advertising world, and this company is one of the top beneficiaries.
The leader in telemedicine is a solid play on our need to cut the costs involved in health care.
It doesn’t matter which companies win the streaming video wars -- this platform provider plays nicely with everyone.